Yuan-xiang Guan
State Key Laboratory Of Oncology In South China, P.R. China
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Perioperative Toripalimab Plus Chemotherapy Versus Chemotherapy Alone in Locally Advanced Gastric or Gastroesophageal Junction Cancer: 3-Year Follow-Up of NEOSUMMIT-01 Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 05, 2026
Adjuvant oxaliplatin with S-1 (SOX) versus S-1 for stage II-III gastric cancer (CAPITAL): A randomized, open-label, phase 3 trial.
Journal: Med (New York, N.Y.)
Published: April 02, 2026
Perioperative tislelizumab plus chemotherapy for locally advanced gastroesophageal junction adenocarcinoma (NEOSUMMIT-03): a prospective, nonrandomized, open-label, phase 2 trial.
Journal: Signal transduction and targeted therapy
Published: July 30, 2024
Author Correction: Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial.
Journal: Nature medicine
Published: January 08, 2024
Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial.
Journal: Nature medicine
Published: June 20, 2023
Time to Local Recurrence as a Predictor of Survival in Adult Head and Neck Soft Tissue Sarcoma.
Journal: The Laryngoscope
Published: May 03, 2022
PD-L1 Expression Is Associated with FOXP3+ Regulatory T-Cell Infiltration of Soft Tissue Sarcoma and Poor Patient Prognosis.
Journal: Journal of Cancer
Published: December 09, 2016
Identification of anaplastic lymphoma kinase break points and oncogenic mutation profiles in acral/mucosal melanomas.
Journal: Pigment cell & melanoma research
Published: February 19, 2013
Time-varying pattern of recurrence risk for gastric cancer patients.
Journal: Medical oncology (Northwood, London, England)
Published: January 18, 2013
The absence of the ERBB4 hotspot mutations in melanomas in patients from southern China.
Journal: Chinese journal of cancer
Published: December 15, 2012
Last Updated: 09/26/2026